High Tower Advisors, LLC Eli Lilly & CO Put Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $289,948 - $363,616	400 Added 133.33%	700 $633,000
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $296,100 - $396,140	-500 Reduced 62.5%	300 $233,000
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $391,791 - $461,870	746 Added 1381.48%	800 $466,000
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $21,300 - $29,365	49 Added 980.0%	54 $29,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $68,394 - $91,451	-195 Reduced 97.5%	5 $2,000
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $62,126 - $72,964	200 New	200 $68,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $224 - $279	1 New	1 $15,000

4,016

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.